Odelaisy Triana-Leon

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Third Allogeneic Stem Cell Transplantation in Children: A Multicenter Analysis From the Spanish GETH-TC Pediatric Group.

Third Allogeneic Stem Cell Transplantation in Children: A Multicenter Analysis From the Spanish GETH-TC Pediatric Group.

Journal: European journal of haematology

Published: February 06, 2026

Outcomes of two distinct T-cell depletion strategies in haploidentical vs unrelated donor pediatric HSCT: A single-center retrospective analysis.

Outcomes of two distinct T-cell depletion strategies in haploidentical vs unrelated donor pediatric HSCT: A single-center retrospective analysis.

Journal: Leukemia research

Published: September 26, 2025

The use of mesenchymal stromal cells in steroid-refractory graft-versus-host disease after pediatric hematopoietic stem cell transplantation: a report of the Spanish group of stem cell transplantation (Geth).

The use of mesenchymal stromal cells in steroid-refractory graft-versus-host disease after pediatric hematopoietic stem cell transplantation: a report of the Spanish group of stem cell transplantation (Geth).

Journal: Bone marrow transplantation

Published: April 21, 2025

Ex Vivo IL-15-Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia.

Ex Vivo IL-15-Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia.

Journal: American journal of hematology

Published: March 06, 2025

Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults.

Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults.

Journal: Experimental hematology & oncology

Published: December 18, 2024

Tandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALL.

Tandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALL.

Journal: EBioMedicine

Published: December 02, 2024

Mathematical Model of CAR T-Cell Therapy for a B-Cell Lymphoma Lymph Node.

Mathematical Model of CAR T-Cell Therapy for a B-Cell Lymphoma Lymph Node.

Journal: Bulletin of mathematical biology

Published: July 31, 2024

Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.

Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.

Journal: International journal of molecular sciences

Published: November 22, 2023

Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.

Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.

Journal: PLoS computational biology

Published: July 31, 2023

Universal scaling laws rule explosive growth in human cancers.

Universal scaling laws rule explosive growth in human cancers.

Journal: Nature physics

Published: December 17, 2020

Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override Immune Suppression in Solid Cancers: A Mathematical Proof of Concept.

Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override Immune Suppression in Solid Cancers: A Mathematical Proof of Concept.

Journal: Cancers

Published: December 04, 2020

Labile haemoglobin as a glycaemic biomarker for patient-specific monitoring of diabetes: mathematical modelling approach.

Labile haemoglobin as a glycaemic biomarker for patient-specific monitoring of diabetes: mathematical modelling approach.

Journal: Journal of the Royal Society, Interface

Published: April 03, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026